PARTICLE VACCINE; CHALLENGE INFECTION; PANDEMIC INFLUENZA; A VACCINE; ANTIBODY; SKIN; DELIVERY; IMMUNITY; IMMUNOGENICITY; EFFICACY
JOURNAL OF CONTROLLED RELEASE, v.172, no.2, pp.579 - 588
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.